Prevention of doxorubicin-induced cardiotoxicity by pharmacological non-hypoxic myocardial preconditioning based on Docosahexaenoic Acid (DHA) and carvedilol direct antioxidant effects: Study protocol for a pilot, randomized, double-blind, controlled trial (CarDHA trial)
Carrasco, Rodrigo; Ramírez, María Cristina; Nes, Kjersti; Schuster, Andrés; Aguayo, Rubén; Morales, Marcelo; Ramos, Cristóbal; Hasson, Daniel; Sotomayor, Mario G.; Henríquez, Pablo; Cortés, Ignacio; Erazo Bahamondes, Marcia; Salas, Claudio; Gormaz, Juan G. (BMC, 2020)